Reuters logo
Drugmaker Valeant's revenue falls 10.5 pct
2017年11月7日 / 中午12点13分 / 13 天前

Drugmaker Valeant's revenue falls 10.5 pct

Nov 7 (Reuters) - Canada’s Valeant Pharmaceuticals International Inc reported a 10.5 percent fall in quarterly revenue on Tuesday, hurt by declining sales in its branded drugs division.

Net income attributable to Valeant was $1.30 billion, or $3.69 per share, in the third quarter ended Sept. 30, compared with a loss of $1.22 billion, or $3.49 per share, a year earlier.

The reported quarter included a tax benefit of about $1.4 billion, the company said.

Total revenue fell to $2.22 billion from $2.48 billion. (Reporting by Ankur Banerjee in Bengaluru; Editing by Sriraj Kalluvila)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below